Target intelligence / Profile preview

Oxidation-related pathways

Molecular classification
Other
01

Overview

Oxidation-related pathways refer to a broad and complex network of biochemical reactions responsible for maintaining cellular redox homeostasis and managing the production and elimination of reactive oxygen species (ROS). These pathways encompass the activity of various antioxidant enzymes, such as superoxide dismutase (SOD), catalase, and the glutathione system, as well as regulatory signaling axes like the Nrf2-Keap1 pathway. In a healthy physiological state, these processes allow ROS to function as important secondary messengers in cell signaling; however, an imbalance leads to oxidative stress, which causes cumulative damage to DNA, proteins, and lipids. Such dysregulation is a central feature in the pathogenesis of many chronic conditions, including cancer, neurodegenerative diseases like Alzheimer's and Parkinson's, and various cardiovascular disorders. Therapeutic interventions in this area generally focus on either neutralizing excessive ROS directly or pharmacologically upregulating the cell's endogenous antioxidant defenses to mitigate tissue injury (Source: NIH, PubMed, PMID: 22759583).

Other names
Oxidative stress pathwaysRedox signaling pathwaysCellular oxidation-reduction processesAntioxidant defense systemsReactive oxygen species metabolism
02

Mechanism of action

Drugs targeting these pathways typically act by activating antioxidant transcription factors like Nrf2 (Nuclear factor erythroid 2-related factor 2), inhibiting enzymes that generate reactive oxygen species such as xanthine oxidase or NADPH oxidase, or directly scavenging free radicals to restore cellular redox balance (Source: PMID: 29019082, PMID: 28551167).

03

Biological functions

Oxidative stress responseMetabolismApoptosisSignal transductionHomeostasisCell death
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationDiabetesAging-related disorders
05

Safety considerations

Potential for interference with essential physiological redox signalingRisk of pro-oxidant effects at high concentrationsLimited clinical efficacy of broad-spectrum antioxidants in human trialsPotential toxicity from systemic metabolic disruption
06

Interacting drugs

Bardoxolone methyl

6 more in the full profile.

07

Biomarkers

8-hydroxy-2'-deoxyguanosine (8-OHdG)Malondialdehyde (MDA)Glutathione/Glutathione disulfide (GSH/GSSG) ratioProtein carbonylsReactive oxygen species (ROS) levels

Beyond the preview

Go deeper on Oxidation-related pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxidation-related pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call